Insider · CIK 0001868494
Whittemore Tingley
Files at TNYA (Tenaya Therapeutics, Inc.). First filing May 16, 2025, latest Feb 17, 2026.
Whittemore Tingley files SEC Form 4 as officer at TNYA (Tenaya Therapeutics, Inc.). Since May 16, 2025, Whittemore Tingley has reported 0 open-market buys worth $0 and 4 open-market sells worth $15k, the latest filed on Feb 17, 2026.
A track record needs three past buys with six months of prices behind them; Whittemore Tingley has 0, so none is measured yet.
The newest scored trade: sold $3,319 of TNYA on Feb 17, 2026, filed Feb 17, 2026, scored 30 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $7,145.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TNYA: Tenaya Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | Tenaya Therapeutics, Inc. | $3,319 5,160 shares | -2% | +63% from low-70% from high | |
| 30Weak | Tenaya Therapeutics, Inc. | $3,826 2,877 shares | -2% | +225% from low-67% from high | |
| 30Weak | Tenaya Therapeutics, Inc. | $6,331 5,053 shares | -3% | +225% from low-67% from high | |
| 30Weak | Tenaya Therapeutics, Inc. | $1,300 2,937 shares | -2% | +16% from low-88% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 17, 2026 | TNYA Tenaya Therapeutics, Inc. | 5,160 0.00% of outstanding | $3,319 | Feb 17, 2026 | none |
| Aug 18, 2025 | TNYA Tenaya Therapeutics, Inc. | 5,053 0.00% of outstanding | $6,331 | Aug 18, 2025 | none |
| Mar 10, 2025 | TNYA Tenaya Therapeutics, Inc. | 7,398 0.00% of outstanding | $3,983 | Mar 10, 2025 | none |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Common Stock | +49,000 | $0.00 | $0 | 263,073 | 32 d ago |
| Sep 10, 2026 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +293,000 | $0.00 | $0 | 293,000 | 32 d ago |
| Feb 17, 2026 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,642 | $0.64 | $1,056 | 222,136 | Feb 17, 2026 |
| Feb 17, 2026 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,642 | $0.64 | $1,056 | 220,494 | Feb 17, 2026 |
| Feb 17, 2026 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,876 | $0.64 | $1,206 | 218,618 | Feb 17, 2026 |
| Feb 3, 2026 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Common Stock | +48,750 | $0.00 | $0 | 223,778 | Feb 5, 2026 |
| Feb 3, 2026 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +318,500 | $0.00 | $0 | 318,500 | Feb 5, 2026 |
| Nov 17, 2025 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -2,877 | $1.33 | $3,826 | 169,926 | Nov 17, 2025 |
| Aug 18, 2025 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,608 | $1.25 | $2,015 | 176,248 | Aug 18, 2025 |
| Aug 18, 2025 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,608 | $1.25 | $2,015 | 174,640 | Aug 18, 2025 |
| Aug 18, 2025 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -1,837 | $1.25 | $2,302 | 172,803 | Aug 18, 2025 |
| May 16, 2025 | TNYA Tenaya Therapeutics, Inc. | SOpen-market sale Common Stock | -2,937 | $0.44 | $1,300 | 171,856 | May 16, 2025 |
Questions about Whittemore Tingley
Answered from the filings on this page, as of the latest one.
Is Whittemore Tingley buying or selling?
In the last 12 months Whittemore Tingley reported 0 open-market buys worth $0 and 2 open-market sells worth $7,145 on SEC Form 4; the latest was sold $3,319 of TNYA on Feb 17, 2026. Grants, option exercises and tax withholding are not counted.
How did Whittemore Tingley's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Whittemore Tingley has 0.
Where does Whittemore Tingley file Form 4?
Whittemore Tingley has filed Form 4 at TNYA (Tenaya Therapeutics, Inc.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.